RBC Emerging Markets Equity Fund NSE:DRREDDY Holdings History
RBC Emerging Markets Equity Fund's Dr Reddy's Laboratories Ltd Holding Summary
As of 2025-03-31, RBC FUNDS TRUST held 4.77 Mil shares of Dr Reddy's Laboratories Ltd(NSE:DRREDDY), totaling ₹63.69 Mil. This investment constitutes 1.62% of their stock portfolio, and RBC FUNDS TRUST now holds 0.57% of the outstanding Dr Reddy's Laboratories Ltd(NSE:DRREDDY) stock.
The initial trade took place in 2019Q3. And since then RBC Emerging Markets Equity Fund has made 13 purchases of NSE:DRREDDY, at an average price of ₹976.28, for a total of 12.24 Mil shares. In addition, there have been 6 sales at an average price of ₹1,215.93 for 7.47 Mil shares. Based on historical transaction data and NSE:DRREDDY's current price of ₹1321.50, RBC Emerging Markets Equity Fund's estimated gain on his NSE:DRREDDY holdings is ₹3.44 Bil, reflecting a 28.76% gain to date.
RBC Emerging Markets Equity Fund NSE:DRREDDY (₹1321.50) Holding Chart
RBC Emerging Markets Equity Fund NSE:DRREDDY (₹1321.50) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price ₹-/Share | ||
Shares Sold | 0 | Average Price ₹-/Share | ||
Current Price ₹0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1